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Highlights 
 It is the first multi-country analysis to explore the association between diabetes and 
hospital admission and mortality among older people, differentiating by 
socioeconomic status. 
 Older people with diabetes are more likely to be admitted to hospital than people 
without diabetes, and more prone to be admitted more often and stay longer.  
 The potential bias in the effect of diabetes on hospital use and death is decreased 
when clinical and functional complications are included. 
 Higher odds of hospital admission are reported by women with diabetes, individuals 
whose age range between 50 to 65 years old or people with medium educational level 
and household income. 
 Diabetes is also significantly related with mortality risk and some differences have 
been reported in terms of socioeconomic status and risk of death.  
 Only people older than 65 years old die later than healthy people.  
 These findings have important implications for public policies to reduce 
socioeconomic-related health inequalities. 
 
Abstract 
The aim of this study is to explain the trends in socioeconomic inequality and diabetes 
outcomes in terms of hospital admission and death in old European people. The sample 













Health, Ageing and Retirement in Europe (SHARE). People being diagnosed of 
diabetes were more likely to be admitted to hospital than those without diabetes, 
although its effect dropped after controlling for clinical and functional complications. 
Largest asscociations were observed in women, people aged 50 to 65 years old, with 
medium educational level and medium household income. Diabetes was significant and 
positively related to mortality in the whole sample. Diabetes is significantly associated 
with mortality risk especially in males, oldest old people, low education and medium 
income people. These findings have important implications for public policies to reduce 
socioeconomic-related health inequalities.  
 
Keywords: Chronic disease; Diabetes; Hospital admission; Death; Socio economic 
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1. INTRODUCTION 
Diabetes is one of the largest factors increasing the risk of mortality, morbidity, and 
disability over the world and its economic burden is a major public health challenge to 
design new ways to curb diabetes health care expenditure (De Lagasnerie et al., 2017). The 
number of people with diabetes has rapidly increased, especially due to the rise of the 
prevalence of Type 2 Diabetes Mellitus (T2DM). Diabetes prevalence has been estimated 
to concern around 380 million people by 2025 all over the world (O´Shea et al., 2013), 
having a greater impact among older people. This increase in next years will be 
accompanied by population ageing, and together with the obesity pandemic, will make 
diabetes incidence greater than in the past.  
Traditionally, the social impact of diabetes has been linked to the use of health and 
social resources, supporting that medical costs for patients with diabetes are up to three 
times higher than costs for patients without the disease (Clarke et al., 2010). Associated 
costs traditionally include visits to physicians, Emergency Room and hospitalization and 
drug costs (Oliva et al., 2004). In fact, the costs associated to the presence of complications 
and hospitalization in people with diabetes explain around 35-40% of the total costs 
(Bruno et al., 2008; Sortso et al., 2016). Hence, current single-disease approach of 
integrated diabetes care should be extended to meet the health care demands of patients 













The aim of this study is to investigate how diabetes is related to hospital admission (and 
number of hospitalizations during the last 12 months and average length of stay per 
hospital admission) and mortality risk (and age at death) among older people in some 
European countries. Moreover, we aim to assess potential trends in such associations by 
socioeconomic groups. We make two important contributions to this literature. First, we 
obtain new evidence about the trends in socioeconomic differences and diabetes outcomes 
from older Europeans, using pooled country data. Second, we investigate why diabetes-
related mortality has recently declined within individuals with diabetes, if so, and it suggests 
us the value of healthcare spending and avoidable mortality that comprises deaths from 
certain conditions ‘‘that should not occur in the presence of timely and effective 
healthcare’’ (Hejink et al., 2013).  
Furthermore, poverty is associated not only with higher diabetes incidence, but also 
with inequality of diabetes care, despite universal health coverage (Hsu et al., 2012). In this 
regard, reducing financial barriers to primary care and pharmacy services may benefit 
diabetic patient populations, especially those in a worse economic condition. Prevalence of 
T2DM is usually higher in more deprived than affluent areas of developed countries, and 
socioeconomic deprivation seems to have a more marked impact on diabetes prevalence 
among women than among men in several populations as Walker et al. (2011) suggest for 
the case of Scotland. They concluded that socio-economic status modifies the association 
between T2DM and mortality so that relative risks for mortality are lower among more 
deprived populations, which was supported by a previous Danish study (Carstensen et al., 
2008). Sortso et al. (2017), also for Denmark, demonstrate that, despite the Danish 
universal health care model, patients with lower and higher education and socioeconomic 
status show different healthcare use patterns. Similarly, for the case of Scotland a low 
socioeconomic status was found to be associated with poorer clinical outcomes for people 
with diabetes admitted to hospital (Wild et al., 2010). Hence, measures of socioeconomic 
status may be valuable in risk scores and in making valid comparisons of the quality of 
diabetes care. However, handling health inequalities can become very complicated and will 
only lead to success when social determinants of health are addressed (Marmot et al., 2012). 
Another study carried out in Germany has already shown that people with lower 
socioeconomic status do not receive the appropriate diabetes care according to their needs 
(Reisig et al., 2007).  
Moreover, in case of the British National Health Service (NHS), Holman et al. (2013) 












hospital stay than those without a register of diabetes diagnosis, being significantly higher 
in small and medium provider trusts, concluding that diabetes may override the usual risk 
factors for hospital mortality. 
Similar results are found in Nishino et al. (2015) also for the NHS and the effect of 
social deprivation and ethnicity on inpatient admissions due to diabetes. The authors 
demonstrate that people living in more deprived areas have higher rates of inpatient 
admissions and readmissions due to diabetes. Another study from the United Kingdom 
showed that mortality declined faster, but emergency hospitalization grew at a higher speed 
in more deprived neighborhoods (Fleetcroft et al., 2017) due to the increased diabetes 
prevalence and patients living longer. Nevertheless, another English study showed that, 
even though people with diabetes and lower socioeconomic status experience diabetes-
related complications more often, they attended the hospital with a lower frequency and 
more to the GP (General Practitioner) consult (Bachmann et al., 2003). Despite all these 
issues and specificities, up to now there are not relevant and comprehensive studies about 
the true economic impact of diabetes focusing on older people nor its components and 
structure.  
The structure of the paper is as follows. Section 2 describes the data and construction of 
the key determinants of socioeconomic differences and diabetes outcomes. In Section 3, 
the econometric model is set within the context of our dataset. After that, the empirical 
findings are presented in Section 4, including discussion of the main results, and Section 5 
concludes, followed by several appendices that include background information. 
 
2. DATA DESCRIPTION  
The Survey of Health, Ageing and Retirement in Europe (SHARE) 
Data for this study were taken from SHARE, which is a longitudinal study from 
individuals aged fifty and over from nineteen European countries, ranging from 
Scandinavia (Denmark and Sweden) through Central Europe (Austria, France, Germany, 
Switzerland, Belgium, and the Netherlands) to the Mediterranean countries (Spain, Italy 
and Greece), and Israel. Information about health status (self-reported health, chronic 
diseases) and healthcare resources use (hospital admission, nursing home admission), 
functional status (number of limitations in Activities of Daily Living, ADLs), 
socioeconomic characteristics (age, gender, country of residence, marital and employment 
status, education, etc.), lifestyle factors (Body Mass Index, smoking habits, alcohol 













We limited our study to sixteen of those countries, namely Austria, Belgium, Czech 
Republic, Denmark, Estonia, France, Germany, Greece, Italy, The Netherlands, Poland, 
Portugal, Slovenia, Spain, Sweden and Switzerland1. We pooled data from five different 
waves: wave 1 (year 2004), wave 2 (year 2006-07), wave 4 (year 2010), wave 5 (year 2013) 
and wave 6 (year 2015)2.  
 
Variables description 
Dependent variables: hospital admission (and number of hospitalizations in the previous twelve months 
and average length of stay per hospitalization) and death (and age at death) 
Bearing in mind the motivation of the paper and the related literature, we took two 
dichotomous variables as two of the main outcomes in our analysis: having been admitted 
to hospital in the last 12 months and having dead between SHARE waves. Moreover, 
within the case of hospital admission, for those individuals who were admitted, we also 
analysed the number of times being admitted to hospital and the average length of stay per 
hospitalization. In case of death, we also used as an outcome the age at the time of death of 
the deceased respondent. 
In case of hospital admission, respondents were asked whether, during the last twelve 
months, they had been in a hospital overnight. Thus, it took value 1 if the respondent had 
been in a hospital overnight in the last twelve months and 0 otherwise. If they answered 
affirmatively, individuals also reported the number of times having stayed overnight in the 
hospital in the last year, as well as the total length of stay, which we will use as well as 
outcome measures in the present analysis. However, we modified the variable length of 
stay. Since the original variable referred to the total number of nights stayed in hospital in 
the previous twelve months, we calculated the mean length of stay per hospital admission 
dividing the total number of nights in hospital by the number of times having been 
admitted to hospital.   
 
Independent variables 
Given the scope of the analysis, self-reported information about doctor’s diagnosis on 
individuals’ chronic conditions and limitations in ADLs was also included. We used six 
dichotomous indicators of chronic medical conditions: chronic lung disease, gastric ulcer, 
                                                          
1 Hungary, Ireland and Luxembourg are not included due to their small size of  sample or because they did not 
appear in, at least, two waves. Israel has also been dropped from the analysis since it is not a European country. 
2 Wave 3 was excluded due to a change in the questionnaire (the SHARELIFE questionnaire), which registered 
information on individuals’ childhood health and, hence, the information provided in these Wave 3 was not 













high cholesterol, hypertension, heart problems (which include heart attack and heart 
failure), stroke and cancer, in addition to diabetes, which was our main disease of interest. 
Since we focus on older adults whose main type of diabetes mellitus is type 2 but the 
dataset does not differentiate between diabetes type, we aimed to identify only those 
respondents with T2DM by applying the following approach:  
1. The first criteria to be identified as having diabetes type 2 was to have answered 
affirmatively that the respondent had been told by a doctor that s/he suffered from 
diabetes. 
2. Then, we also classified respondents as diabetes type 2 people if they replied they 
were taking drugs for diabetes. 
3. Finally, we used information from the SHARELIFE questionnaire (wave 3) on 
childhood health to drop those individuals who answered they already suffered from 
diabetes when they were children.  
Furthermore, in order to have some measure of functional impairment, SHARE 
includes data on the Katz Activities of ADLs Index used since 1963 (Katz et al., 1963), 
which evaluates functional status as a measurement of the person’s ability to carry out six 
activities of daily living independently (bathing, dressing, toileting, transferring, continence 
and feeding). Survey respondents were asked about their limitations when carrying out each 
of these activities. According to their responses, four categories were generated referring to 
functional impairment: i) no impairment if respondents had no limitation when performing 
any of the ADLs; ii) mild functional impairment if respondents felt being limited in a 
maximum of two ADLs; iii) moderate functional impairment if participants perceived they 
had some limitations in three to five of these activities; and iv) severe functional 
impairment when individuals were limited in all ADLs.  
We also included some sociodemographic variables at their baseline value to deal with 
endogeneity. Such sociodemographic variables were age, gender, marital and employment 
status and education level, as well as some healthy lifestyle factors3 (Body Mass Index 
categories and being a current smoker). Finally, dummy variables for each European 
country and wave of SHARE were included. 
 
Summary statistics 
                                                          
3 Alcohol consumption was not included in the analysis due to the response bias that could exist given the 
sensitivity of  the topic. Moreover, frequency of  alcohol consumption in the last three months reported a high 













In the main analysis, we consider the population aged 50 years old and above. Summary 
statistics, as well as a comparison of means test, are reported in Table A1, Appendix.  
Our sample from SHARE consisted of 73,301 individuals, of whom around 13% of the 
sample reported to have diabetes. 
Hospital admission rates were higher in people with diabetes than in those without the 
disease (21.97% and 13.42%, respectively), with a higher mean number of times being 
admitted (1.82 vs 1.63) and a higher length of stay per hospital admission (8.55 days vs 7.05 
days) in the previous twelve months. Moreover, death rates were higher in individuals with 
diabetes (8.14% in people with diabetes vs 4.73% in those without), with a slight younger 
age at death. 
People with diabetes are older (69.56 vs 66.25 years old), less likely to be female (53.75% 
vs 57.82%) and to be employed (12.97% vs 28.14%) when compared to their counterparts. 
Moreover, the mean annual household income is lower in respondents with diabetes 
(24,460.71) than in those who do not suffer from the disease (30,709.27). Individuals with 
diabetes are more prone to be less educated than those without (6.95% vs 3.80% in case of 
no education; 18.63% vs 17.50% in case of low secondary education or below) and to be 
obese (38.80% vs 18.11%). With respect to health and functional status, significant 
differences were observed between both subsamples, with people with diabetes reporting 
higher diseases prevalence than the individuals without the disease. For example, the 
prevalence rate of hypertension, heart problems, stroke and mild functional impairment in 
people with diabetes were 61.92%, 24.02%, 7.01% and 15.77%, respectively, compared to 
the group of people without diabetes, which reached 35.37%, 12.14%, 3.21% and 7.9%, 
respectively.   
 
3.  METHODOLOGY 
Given the high proportion of people not having been admitted to hospital and people 
alive, we applied two-part models on both outcomes. Two-part models combine a model 
for the binary response variable, which would be having been admitted to hospital 
overnight and having died between SHARE waves, and a model for the outcome variable 
that is conditioned on the binary response (Farewell et al., 2017), conditional on having 
stayed in hospital overnight or having died. The outcome variables conditional on the 
binary response from the first model will be number of times being admitted to hospital 
and mean length of stay per hospital admission in case of hospitalization, and age at death 













The first stage defines a dichotomous variable R indicating the regime into which 
observations of the dependent variable y falls (Frondel and Vance, 2011):  
𝑅 = 1, 𝑖𝑓 𝑦∗ = 𝑥1
𝑇𝜏 +  𝜖1 > 0  𝑎𝑛𝑑 𝑅 = 0 , 𝑖𝑓 𝑦
∗ ≤ 0  (1) 
where y∗ is a latent variable, which would denote having been admitted to hospital (vs 
no hospital admission) or having died (vs being alive); the vector x1 denotes its 
determinants, which would be the independent variables aforementioned; τ is a vector of 
associated parameters, and 𝜖1 is an error term with a standard normal distribution. R = 1 
indicates that y* > 0 (having been admitted to hospital at least once at least for one day; or 
having died at a certain age), whereas R = 0 is equivalent to y* = 0 (not admitted to hospital 
or alive).  
After estimating τ using logit estimation techniques, the second stage involves a 
Generalized Linear Model (GLM) with Poisson distribution and log link regression of the 
parameters β that affect the expected value E[y|y > 0] conditional on y > 0, i. e. , R = 1:  
𝐸[𝑦 |𝑅 = 1, 𝑥2] = 𝐸[𝑦|𝑦 > 0, 𝑥2] = 𝑥2
𝑇𝛽 + 𝐸(𝜖2 |𝑌 > 0, 𝑋2)   (2) 
where x2 includes the determinants of the dependent variable y, which will be the same 
used as in equation (1); and 𝜖2  is another error term. The expected value of the dependent 
variable y (hospital admission and death) then consists of two parts, with the first part 
resulting from the first stage (1), 𝑃(𝑦 > 0) =  𝜱(𝒙𝟏
𝑻𝜏), and the second part being the 
conditional expectation E[y|y > 0] from the second stage (2).  
However, given the panel nature of our data (SHARE survey), we can decide between 
two techniques, fixed-effects and random-effects models, to run the first part of the two-
part models of our analyses (Heij et al., 2004; Berrington et al., 2006). Fixed-effects models 
aim to analyze the causes of changes within an individual. On the contrary, random-effects 
models do allow time-invariant factors to be associated with the outcome. We will perform 
a Hausman test on each outcome to choose between the random and the fixed-effects 
estimation (Greene, 2012)4.   
Taking into account the fact that having been admitted to hospital is a dummy variable, 
the baseline logistic regression model with fixed-effects for hospital admission is as follows:  
 𝑃𝑟[𝐻𝑜𝑠𝐴𝑑𝑚𝑖𝑡 = 1 |𝑥𝑖𝑡] = Λ( 𝛽0 +  𝛽1𝑆𝐸´𝑖𝑡 ∗ 𝑇𝑡 +  𝛽2𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠𝑖𝑡 + 𝛾𝑐𝐶𝑐 +  𝜑𝑡𝑇𝑡 +
𝑢𝑖𝑡)    (3 1) 
where i represents the individual, c country, and t year.  𝐻𝑜𝑠𝐴𝑑𝑚𝑖𝑡  is a dummy variable 
indicating that respondent i has been admitted to hospital in the last 12 months in year t. Λ 
                                                          
4 According to the Hausman test, fixed-effects models should be used for hospital admission and random-













is the logistic function, Λ(𝑡) = 𝑒𝑡/(1 + 𝑒𝑡), with values ranging from zero to one. 𝑥𝑖𝑡 =
(SEit, diabetesit, country dummies, time dummies)′ is a vector of explanatory 
variables. SEit and diabetesit denote the set of socioeconomic variables at baseline and the 
dummy variable for having diabetes, respectively; 𝛾𝑐 represents the coefficient for the 
country-specific dummies, having c-1 variables introduced in the model; 𝜑𝑡 is the 
coefficient for the binary time variable; 𝑇𝑡 represents time as a dichotomous variable, 
having t-1 time periods; and 𝑢𝑖𝑡 denotes the error term.  
Four different regression models will be run in this paper. Firstly, Model A adjusted for 
sociodemographic characteristics (age, gender, marital and employment status, and 
education level at their baseline values), healthy lifestyle factors (having underweight, 
overweight or obesity, and being a current smoker at their original values in the first wave 
of participation) and having diabetes, as well as time and country dummies, as it has been 
outlined in the explanation of equation (3). In this model, diabetes was the only chronic 
condition included. In Model B, we also control for non-related diabetes clinical 
complications, such as chronic lung disease, and gastric ulcer. However, some diseases, 
which are diabetes-related, are not included. These were included in model C (cancer, 
cardiovascular risk factors (hypertension and cholesterol), and cardiovascular diseases 
(heart problems and stroke). Moreover, to also account for the association between 
diabetes and functional impairment as people get older, we added in Model D the three 
categories referring to functional impairment, being the reference category no functional 
impairment: mild, moderate and severe impairment. 
Same procedure was followed for our second outcome of interest, having died between 
SHARE waves, but using random effects specifications. We will evaluate potential 
differences in the age at death by using Kaplan-Meier survival curves and the log-rank test, 
which compares survival curves by diabetes status. 
To analyze potential differences by socioeconomic status, we will run the estimation 
also by gender (females and males), age groups (age 50 – 65, 65 – 80 and individuals older 
than 80 years old), educational level, household income and country groups. Educational 
level was divided into three different groups: low education (no education and low 
secondary education), medium education (upper secondary education and non-tertiary 
education) and high education (short tertiary education and bachelor). Additionally, three 
diverse groups were generated for household income, creating three quintiles of annual 
household income: low household income, which ranged from 0€ to 14,135.92€; medium 













values equal or above 29,084.47€. Finally, countries were grouped according to their 
geographical area into four groups: Central and Eastern Europe (Czech Republic, Poland, 
Slovenia); Northern Europe (Denmark, Estonia, Sweden); Southern Europe (Greece, Italy, 
Portugal, Spain); and Western Europe (Austria, Belgium, Germany, France, The 
Netherlands, Switzerland). 
All the statistical analyses were performed using STATA 14.0 software (Stata 
Corporation, College Station, TX). 
 
4. EMPIRICAL RESULTS 
In this section, we present the estimation results of the effect of diabetes on the 
probability of having been admitted to hospital in the previous twelve months and the 
likelihood of having died between SHARE waves and by socioeconomic status.  
   
Diabetes and hospital admission 
Table 2 shows the average marginal effects of diabetes for having been admitted to 
hospital, as well as the coefficient for the number of times having been admitted in the 
previous twelve months and the mean length of hospital admission per stay. More detailed 
results on the four regression models and the other covariates can be found in Table A2, 
Appendix. 
Model A shows that a new diagnosis of diabetes5 between waves is associated with a 
significant increase in the probability of being admitted to hospital by 1 percentage points 
(p.p.), the number of hospital admissions by 7.66 percentage points and the mean length of 
stay per hospital admission by 11.5%. In case non-diabetes related complications are 
included, Model B, diabetes association effect falls to 0.93 p.p., but still significant. The 
number of hospital admissions and the average length of stay follow the same trend, whose 
coefficients for the diabetes variable drop to 7.42% and 11.3%, respectively. Chronic lung 
disease is associated with an increase in the risk of being hospitalized by 9.24 p.p., but the 
increase in the number of times being hospitalized increases in a larger amount than in case 
of diabetes (by 10%) (Table A2, Appendix). The drop in the diabetes effect is greater when 
clinical complications are included in the analysis, falling to 0.68 p.p., and increasing again 
to 0.87 p.p. when functional complications are included (Table 2). Diabetes is related to an 
                                                          
5 Since fixed-effects logistic regression models are used for hospital admission, average marginal effects could 
be interpreted as the effect on the probability of  being admitted to hospital from a one-unit change in any of  
the independent variables. That is why when the average marginal effect of  diabetes is explained, we refer to a 
new diabetes diagnosis (that is, changing the value of  the diabetes variable from 0 (no diabetes) to 1 (having 













increase in the number of times being admitted to hospital by 6.83% and 5.79% in models 
C and D, respectively. Being diagnosed of diabetes is associated with a higher mean length 
of stay, in days, by 12.1% in model C and by 9.12% in model D, when both clinical and 
functional complications are included. In Model C, suffering from cancer is the clinical 
complication associated with a higher increase in the probability of being admitted to 
hospital and the number of hospitalizations6 (Table A2, Appendix). Stroke is the clinical 
complication associated with the largest effect on the mean length of stay. In Model D, it is 
severe functional impairment the complication related to the largest increase of the 
likelihood of hospitalization, as well as the number of times being admitted to hospital and 
the mean length of stay. 
The results show that the potential bias in the estimated association of diabetes and 
hospital use is reduced when clinical and functional complications are included. This 
conclusion would be in line with previous findings about diabetes and healthcare resource 
use among older people (Rodríguez-Sánchez et al., 2017), signaling the overestimation of 
the diabetes effect if comorbidities are not considered in the analysis (Struijs et al., 2006). 
 
Diabetes and hospital admission by socioeconomic status 
When we run the analysis according to gender (Table 2), diabetes is significant and 
positively related with hospital admission for both women and men in Model A, when 
diabetes is the only clinical variable included in the estimation. Diabetes is associated with 
an increase in the risk of being admitted to hospital by 1.15 p.p. in women and 0.76 p.p. in 
men. When all clinical and functional complications enter the regression (Model D), 
diabetes is a significant predictor of hospital admission only for women. In females, being 
diagnosed of diabetes is associated with a higher risk of hospitalization by 0.99 p.p. Severe 
functional impairment is associated with the higher increase of the probability of being 
hospitalized, by 5.10 p.p. (Table A3, Appendix). For men, it is also severe functional 
impairment the main driver of hospital admission, increasing the risk by 4.48 percentage 
points. In both females and males, diabetes is associated with a greater number of hospital 
admissions and mean length of stay, with a greater impact on women than men (Table 2).  
In case of stratification by age (Table 2), diabetes and hospital admission are significant 
and positively related only in those individuals aged 50 to 65 years old, but only when 
diabetes was the only clinical complication included. Diabetes is associated with an increase 
                                                          
6 This result should be interpreted with caution as around 5% of  the sample has reported to have been 
diagnosed of  cancer. This group of  individuals might have had a planned hospitalization for chemotherapy 













in the risk of being admitted to hospital by 4.83 percentage points. When all clinical and 
functional complications enter the regression, the main drivers of hospitalization differ 
between age groups. For the youngest subgroup, moderate functional impairment (AME = 
21.8 p.p.) is associated with a higher hospital admission risk (Table A4, Appendix). For 
those aged 66 to 80 years old, severe (AME = 0.92 p.p.) functional impairment is related to 
the greatest increase in the probability of hospital admission. Diabetes is significantly 
associated with the number of hospital admission and the average length of stay in those 
aged 50 to 65 years old and in people aged 66 to 80 years old, reporting a larger association 
in the former group (Table 2). 
Diabetes stands as a significant predictor of hospital admission for those individuals 
with low and medium education, but only when clinical and functional complciations are 
not included (Table 2). Diabetes is associated with an increase in the likelihood by 1.72 p.p. 
in Model A for low educated individuals and by 1.32 p.p. in medium educated people. 
When all clinical and functional complications enter the regression, the main drivers of 
hospitalization also differ across education level. For the low-educated people, cancer 
(AME = 5.51 p.p.) is the complication associated with the greatest increase in the risk of 
being admitted to hospital. For the middle-educated subgroup, severe mild functional 
impairment (AME = 5.87 percentage points) is related to the greatest increase in the 
probability of hospital admission. In case of the high-educated ones, cancer (AME = 2.21 
p.p.) is associated with the largest rise in the probability of hospital admission (Table A5, 
Appendix). Diabetes is significantly associated with the number of hospital admission and 
the average length of stay in those with medium education, regardless of the variables 
included in the regression model. In the low educated survey respondents, diabetes is 
associated with an increase in the number of hospitalizations. 
When we divide the sample according to household income (Table 2), diabetes is 
significant and positively related with the probability of being admitted to hospital only in 
those individuals with medium household income in both Models A and D. Diabetes is 
associated with an increase in the risk of hospital admission by 4.54 and 4.98 percentage 
points, respectively. When all clinical and functional complications are part of the analysis, 
significant associations between complications and hospital admission also vary across 
income groups. In the low-income individuals, severe functional impairment is associated 
with a higher risk of hospital admission by 1.36 p.p. and by 13.4 p.p. in case of middle-
income indiviuals (Table A6, Appendix). On the other hand, cancer (AME = 2.85 p.p.) is 













Diabetes is significantly associated with the number of hospital admission and the average 
length of stay in every household income group, reporting a larger association in the 
highest household income survey respondents (Table 2). 
Hence, our findings are consistent with previous results found in the literature (Nishino 
et al., 2015), showing that diabetes does vary the risk of being admitted to hospital by 
socioeconomic group, although the significant impact of diabetes depends on the 
covariates included in the regression model. However, our results should be interpreted 
with caution, as we are not trying to disentangle and to understand inequalities in diabetes 
outcomes (hospital admission and mortality), as it has been previously done in the literature 
(Sortso et al., 2016; Lamy et al., 2017). If we aim to disentangle inequalities, we could also 
infer differences in diabetes prevalence and incidence due to the socioeconomic group and 
how such differences would lead to different patterns of healthcare resources use. In spite 
of not being fully comparable studies, it could also be concluded from our analyses that the 
use of healthcare services differs between socioeconomic groups.  
 
Diabetes and hospital admission by country group 
When we stratify the sample by country group (Table 2), diabetes and hospital 
admission are significant and positively related only in those individuals living in Southern 
and Western European countries, when clinical and functional complications are excluded. 
Diabetes is associated with an increase in the risk of being admitted to hospital by 3.37 p.p. 
in Model A in case of Southern European countries and by 0.71 p.p. if Western countries.  
When all clinical and functional complications enter the regression, the main drivers of 
hospitalization differ between countries (Table A7, Appendix). In Central and Eastern 
European countries, no complication is significantly related to hospital admission 
likelihood. In Southern and Western European countries, severe functional impairment 
(AME = 22.7 p.p. in Southern countries and AME = 3.73 p.p. in Western Europe) is 
associated with a higher hospital admission risk. For those residents in Northern countries, 
cancer (AME = 1.36 p.p.) is related to the greatest increase in the probability of 
hospitalization. Diabetes is significantly associated with the number of hospital admission 
and the average length of stay in every country group, except for Northern European 
countries, reporting the largest associations in case of people living in Western countries 
(Table 2). 
 













Table 3 shows the average marginal effects of diabetes for having died between SHARE 
waves, as well as the coefficient for the age at death of the deceased. Table A8, Appendix, 
displays the detailed results from the four models and the whole set of covariates. 
Model A shows that having diabetes is significantly associated with an increase in the 
probability of dying by 2.77 p.p. However, diabetes is not significantly related to the age at 
death of the deceased (Table 3). In case non-diabetes related complications are included, 
Model B, diabetes effect falls to 2.72 p.p., but still significant (Table A8, Appendix). 
Chronic lung disease is associated with a higher risk of death by 3.29 p.p., and with a lower 
age at death by 0.25 years. The drop in the diabetes effect is greater when clinical 
complications are included in the analysis, falling to 2.63 p.p. (Table A8, Appendix), and to 
2.30 p.p. (Table 3) when functional complications are included. In Model C, suffering from 
cancer is the clinical complication associated with the largest increase in the probability of 
death and with the largest decrease in the age at death of the deceased. In Model D, it is 
severe functional impairment the complication associated with the greatest increase in the 
mortality risk, as well as with the lowest reduction in the age at death. 
Our results show that, although we controlled for clinical and functional complication, 
diabetes is significantly related with mortality risk, contradicting some authors (Fleetcroft et 
al., 2017) who concluded that, at least in the United Kingdom, there is a trend in the 
mortality decline due to diabetes. The difference might be due to country-specific caseness, 
as the United Kingdom was not included in our analysis.  
 
Diabetes and mortality by socioeconomic status 
When we run the analysis according to gender (Table 3), diabetes is significant and 
positively related with mortality risk for both women and men, regardless of the covariates 
included. Diabetes is associated with an increase in the death likelihood by 1.89 p.p. (Model 
A) and 1.64 p.p. (Model D) in women, whereas these coefficients increase to 3.24 p.p. and 
2.69 p.p., respectively, in men. In both women and men, severe functional impairment is 
related to the largest increase in the probability of dying, by 7.11 p.p. and 11.4 p.p., 
respectively (Table A9, Appendix). However, diabetes is never associated with the age at 
death, regardless of gender (Table 3).  
In case of stratification by age (Table 3), diabetes and mortality are significant and 
positively related in every age group. Diabetes is associated with an increase in the risk of 
death by 1.79 p.p. and 1.63 p.p. in models A and D, respectively, in those individuals aged 
50 to 65 years old. These effects increase to 5.57 p.p. and 4.64 p.p. among subjects older 













age groups. When all clinical and functional complications enter the regression, the main 
drivers of mortality differ between age groups (Table A10, Appendix). For the youngest 
subgroup, severe functional impairment (AME = 6.77 p.p.) is associated with a higher risk 
of death, rising to 21.0 p.p. in those aged 66 to 80 years old and 33.6 p.p. in the oldest 
subgroup.  
Diabetes stands as a significant predictor of death in every educational level group 
(Table 3). In low educated individuals, diabetes is associated with an increase in the 
likelihood of dying by 2.18 and 1.56 p.p. in Model A and D, respectively, when all clinical 
and functional complications are included. In case of middle-educated individuals, diabetes 
is related to a higher risk of death by 1.97 p.p. only in Model A, but non-significant in 
Model D, when both clinical and functional complications are part of the analysis. For 
those people with high education, diabetes is associated with an increase of the odds of 
dying by 1.39 and 1.27 p.p. Diabetes is never significantly associated with the age at death 
in the education groups. When all clinical and functional complications enter the 
regression, the main drivers of mortality also differ across education level (Table A11, 
Appendix). For low and high-educated individuals, severe functional impairment (AME = 
10.2 in case of low educated individuals; and AME = 4.99 in people with high education) is 
the complication associated with the greatest increase in the risk of dying.  
When the sample is divided by household income (Table 3), diabetes is significant and 
positively related with the probability of death in every household income group. In low 
income individuals, diabetes is related to an increase in the likelihood of dying by 3.26 and 
2.73 p.p. in Model A and D, respectively, when all clinical and functional complications are 
included. In case of people with medium household income, diabetes is related to a rise in 
the risk of death by 3.72 and 3.16 p.p., respectively. For those people with high income, 
diabetes is associated with an increase the odds of dying by 1.43 and 1.06 p.p. Diabetes is 
significantly associated with the age at death in both people with medium and high 
household income, but with opposite sign: in case of the former, suffering from diabetes 
increases the age at death, whereas in case of those with high household income, having 
diabetes is associated with an earlier age at death. When all clinical and functional 
complications enter the regression, the main drivers of mortality also vary across household 
income group (Table A12, Appendix). For all household income level, severe functional 
impairment (AME = 20.1 p.p. in case of low-income individuals; AME = 20.4 p.p. in 
people with medium household income and AME = 10.4 p.p. in high-income people) is 













As it has been mentioned when discussing the results on diabetes and hospital 
admission by socioeconomic group, also in case of mortality, our aim is not to disentangle 
the pathway between socioeconomic status and morbidity, which might lead to death. 
However, our results might be comparable in terms of the association between 
socioeconomic status and risk of mortality with the results obtained by Sortso et al. (2016; 
2018). The authors found that individuals with high education and income have lower risks 
of death than those with short education and low income, respectively.  
Figure 1 shows the Kaplan-Meier curves for the age at death by diabetes status by 
population group. In case of people aged 65 years old and above, individuals with diabetes 
die before than healthy people7. Our results would contradict those previously reported in 
the literature among European populations concluding that mortality trends in people with 
diabetes depend on socioeconomic position, with greater inequalities between genders 
(Espelt et al., 2011). We found no statistical differences in the age at death by gender, 
education or income; we did find differences in terms of age. 
 
Diabetes and mortality by country group 
When the analysis is made by country group (Table 3), diabetes and mortality risk are 
significant and positively related in every country group, regardless of the covariates 
included in the analysis. Diabetes is associated with an increase in the risk of dying by 2.70 
p.p. in Model A in case of Central & Eastern European countries and by 2.25 p.p. in Model 
D. In Northern countries, diabetes is related to a higher probability of death by 2.89 and 
2.34 p.p. in Models A and D, respectively. The largest association between diabetes and 
mortality risk is shown in Southern countries, where diabetes is associated with an increase 
in the death risk by 4.48 and 3.66 p.p., respectively. Finally, in Western countries, diabetes 
is related with a higher probability of dying by 1.87 and 1.61 p.p. in Model A, when 
diabetes is the only clinical variable included, and Model D, when all functional and clinical 
complications are included. No significant association between diabetes and age at death is 
reported in any group of countries. 
When all clinical and functional complications enter the regression, the main driver of 
higher risk of death within th listed complications is severe functional impairment (Table 
A13, Appendix), although its average marginal effect ranges from 16.8 p.p. in Western 
countries to 21.5 p.p. in Southern countries.  
                                                          
7 Healthy people refers to the healthy individuals with no diabetes nor any other chronic disease included in the 
analysis (chronic lung disease, gastric ulcer, cancer, high blood pressure, cholesterol, heart problems, stroke, 
















Diabetes is significantly related to both outcomes, the risk of death and hospital 
admission, with significant differences across socioeconomic groups and countries. 
Moreover, our results also show that such differences are also observed in specific 
characteristics of hospitalization (number of hospital admission and mean length of stay 
per hospitalization) and death (age at death of the deceased).  
We have demonstrated that the effect of diabetes on hospital utilization and mortality is 
influenced by clinical and functional complications. We have observed differences by 
socioeconomic status: higher odds of hospital admission are found in women with 
diabetes, individuals whose age range between 50 to 65 years old or people with medium 
educational level and household income. Some studies have already reported that, after 
controling for need, the use of healthcare resources is greater among higher-income groups 
(van Doorslaer et al., 2004a; 2004b). Moreover, some studies among older populations 
have also shown differences in healthcare use by income (Merlo et al., 2003; Allin et al., 
2006) and education (Santos-Eggimenn et al., 2005). On the other hand, males, older 
people, low educated people and individuals with medium household income are associated 
with greater mortality risk. The differences between effects education and income, which 
might be used as indicators of socioeconomic status, may reflect reverse causality, with 
incomes being influenced by the individuals´ morbidity status. However, the reverse 
causality between education and morbidity should be lower, since the education level might 
have been acquired before the morbidity appears. More research will be needed to confirm 
our interpretation because there were mixed reactions to this econometric analysis. Still, 
previous authors have confirmed the gender differences that have been found in terms of 
diabetes outcomes, suggesting that men have higher mortality rates (Gregg et al., 2007; 
Kivimäki et al., 2018), whereas women show to be more likely to he admitted to hospital 
(Schneider et al., 2016). Such disparities between males and females could be due to 
variations in diabetes severity (Kautzky-Willer et al., 2016; Kivimäki et al., 2018) with 
respect to lifestyles and diabetes-related complications. 
Broadly, several implications can be obtained from the above findings. First, differences 
in the effect of diabetes with regards to comorbidity and clinical and functional 
complications should be widely studied due to their role in rising cost of diabetes. Second, 
special attention should be paid to people in advancing age and with low socioeconomic 
status, confirming the empirical results reported by previous authors (Reisig et al., 2007; 













between socioeconomic status and morbidity to get rid of endogeneity issues that could be 
present in the associations analysed in the current paper. Measurement and understanding 
of socioeconomic inequalities in health and health care are critical for achieving higher 
equity in health care (Sortso et al., 2016; 2017). 
Hence, the consistency of our findings across countries included in SHARE would be 
of great relevance for governments and policymakers to be aware of diabetes burden on 
health outcomes among older adults, especially on hospital admission, as nearly 35–40% of 
diabetes-related costs are associated with the management of vascular complications and 
hospital admission (Clarke et al., 2010). Moreover, comorbidity should not be neglected 
when assessing diabetes impact, as we have shown that clinical complications play a key 
role lowering potential bias, but functional impairment should not be excluded either: being 
limited in the activities of daily living increases diabetes-related costs of care by three folds 
compared with costs of those who are independent in old people (Sinclair et al., 2015). 
Without controlling for diabetes-related conditions and functional impairment as we are 
doing in the current analysis, the estimated coefficients could be imprecise due to 
endogeneity, as those obtained in model A, which excludes those variables.  
However, some limitations should also be mentioned. Firstly, data on clinical 
conditions, such as diabetes, is self-reported by respondents, possibly leading to recall bias 
and the results could either over or underestimate the real impact of diabetes and other 
self-reported covariates on both outcomes. However, data from health conditions collected 
using self-reported information is reliable according to the existing literature (Goebeler et 
al., 2007; Dal Grande et al., 2012). Secondly, some authors (Norlund et al., 2001; 
Rodríguez-Sánchez and Cantarero-Prieto, 2017) have already reported that, when 
evaluating the effect of diabetes, researchers should consider the role of endogeneity. 
Nevertheless, we did not have more detailed information about diabetes (family history or 
time since diagnosis) in SHARE dataset, which could be implemented in further research 
using additional data. Thus, what we have done is using other health factors which could be 
related to the development of diabetes, such as having overweight or obesity, smoking 
habits and a set of clinical and functional complications, which have been described before. 
Thirdly, quality of the data collected is assured, controlling for potential differences 
between countries. Response rates between countries in SHARE data range from 40.3% in 
Belgium to 97.6% in France during wave 1 (Bergmann et al., 2017). Moreover, the quality 
of the data collection is guaranteed across countries through what has been called the 













of working the sample completely to reduce non-response rates and the importance of the 
representativeness in the random sample. In many countries, incentives schemes were 
applied to ensure interviewers´ motivation, who were even paid for lower non-response 
rates. Furthermore, to reduce any potential bias from the data collection process, at the 
beginning of the development of the SHARE data, a sampling weight was designed and 
applied to every subsequent collection of data. By doing so, oversampling of some 
populations or countries would be minimized, although it is true that in many European 
countries there either exist no national sampling frame or access to a national sampling 
frame.  
Achieving lower inequalities in diabetes among old people are likely to require complex 
interventions as they might require integrated care between the different healthcare 
providers and professionals. An appropriate provision of medical advice and attention, 
such as diabetes management, could also help to reduce inequalities in terms of quality of 
care and also decrease preventable hospitalizations (Bachmann et al., 2003; Espelt et al., 
2011; Fleetcroft et al., 2017).  
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Table 1: Summary Statistics for the whole sample and by diabetes status8 
VARIABLES 
Whole sample   
(N = 173,208) 
People with 
diabetes            
(N = 21,584) 
People 
without 
diabetes            




Hospital use     
Hospital admission 14.52 21.97 13.42 0.000*** 
Number of times admitted to 
hospital, if admitted (SD) 
1.67 (1.51) 1.82 (1.63) 1.63 (1.48) 0.000*** 
Length of stay per hospital stay, 
if admitted (SD) 
7.34 (11.96) 8.55 (14.00) 7.05 (11.39) 0.000*** 
Death     
Dead 5.17 8.14 4.73 0.000*** 
Age at death, if dead (SD) 79.47 (9.94) 78.78 (9.19) 79.65 (10.11) 0.000*** 
Diabetes 12.88 - -  
Age (SD) 66.67 (9.82) 69.56 (9.24) 66.25 (9.83) 0.000*** 
Female 57.29 53.75 57.82 0.000*** 
Married 70.26 66.89 70.75 0.000*** 
Employment status    0.000*** 
Retired 56.61 67.25 55.03  
Employed 26.19 12.97 28.14  
Disabled  3.23 5.21 2.93  
Education    0.012** 
No education 4.21 6.95 3.80  
Low secondary education 17.65 18.63 17.50  
Upper secondary education 31.08 27.78 31.57  
Non-tertiary education 4.25 3.73 4.33  
Short tertiary education 20.25 13.81 21.20  
Bachelor 0.74 0.50 0.78  








Body Mass Index (BMI) categories    0.000*** 
Underweight 1.15 0.47 1.26  
                                                          














Whole sample   
(N = 173,208) 
People with 
diabetes            
(N = 21,584) 
People 
without 
diabetes            




Normal weight 36.26 19.60 38.72  
Overweight 41.81 41.13 41.91  
Obesity 20.78 38.80 18.11  
Current smoker 15.31 12.64 15.70 0.000*** 
Chronic conditions     
Chronic lung disease 5.69 8.40 5.29 0.000*** 
Gastric ulcer 4.58 5.65 4.42 0.000*** 
Cancer 4.76 5.68 4.63 0.000*** 
Hypertension 38.79 61.92 35.37 0.000*** 
Cholesterol 23.40 40.19 20.92 0.000*** 
Heart problems 13.67 24.02 12.14 0.000*** 
Stroke  3.70 7.01 3.21 0.000*** 
Functional impairment    0.000*** 
No ADL impairment 89.28 80.14 90.63  
Mild ADL impairment 8.91 15.77 7.90  
Moderate ADL impairment 1.15 2.66 0.92  
Severe ADL impairment 0.65 1.42 0.54  
Countries    0.000*** 
Austria 6.99 6.64 7.04  
Germany 6.63 6.81 6.60  
Sweden 6.84 5.43 7.05  
The Netherlands 5.12 3.97 5.29  
Spain 8.28 10.97 7.89  
Italy 7.75 7.80 7.74  
France 8.56 7.59 8.93  
Denmark 6.90 3.88 6.27  
Greece 3.77 3.25 3.84  
Switzerland 5.26 2.94 5.61  
Belgium 9.62 8.09 9.85  














Whole sample   
(N = 173,208) 
People with 
diabetes            
(N = 21,584) 
People 
without 
diabetes            




Poland 2.17 2.29 2.16  
Portugal 1.23 2.01 1.12  
Slovenia 3.57 3.80 3.53  
Estonia 7.79 8.03 7.75  
Waves    0.000*** 
Wave 1 (year 2004) 11.44 8.51 11.86  
Wave 2 (year 2006/07) 16.87 15.19 17.12  
Wave 4 (year 2010) 24.89 24.98 24.88  
Wave 5 (year 2013) 30.62 32.56 30.34  
Wave 6 (year 2015) 16.18 18.76 15.80  















Table 2: Two-part model: results of the effect of diabetes from the fixed-effects logit model for 
having been admitted to hospital in the last twelve months and the GLM models for the number of 























































stay    
Model D 
Whole Sample  
(N(obs) = 173,208; 
N(individuals) =73,301)  
 
0.00993*** 0.0766*** 0.115*** 0.00870** 0.0579*** 0.0912*** 
(0.00331) (0.0153) (0.0272) (0.00397) (0.0152) (0.0269) 
Gender       
Female (N(obs) = 99,194; 
N(individuals) =40,765)  
0.0115** 0.0778*** 0.0335 0.00987* 0.0596*** 0.0104 
(0.00500) (0.0208) (0.0369) (0.00543) (0.0210) (0.0369) 
Male (N(obs) = 74,014; 
N(individuals) =32,536) 
0.00758* 0.0752*** 0.213*** 0.00665 0.0544** 0.190*** 
(0.00412) (0.0227) (0.0397) (0.00574) (0.0221) (0.0390) 
Chow-test p-value for significant 
differences between genders 
0.019** 0.030** 
       
Age group       
Age 50 - 65 (N(obs) = 83,390; 
N(individuals) =41,964)  
0.0483** 0.107*** 0.118** 0.0339 0.0874*** 0.122** 
(0.0230) (0.0284) (0.0534) (0.0227) (0.0281) (0.0553) 
Age 65 - 80 (N(obs) = 71,146; 
N(individuals) =36,038) 
0.000666 0.0552*** 0.136*** 0.000214 0.0350* 0.0936*** 
(0.000849) (0.0212) (0.0353) (0.00123) (0.0208) (0.0341) 
Age 80+ (N(obs) = 18,672; 
N(individuals) =10,436) 
0.00115 0.0697* 0.0515 0.00143 0.0532 0.0214 
(0.00146) (0.0359) (0.0671) (0.00347) (0.0366) (0.0656) 
Chow-test p-value for significant 
differences between age groups 
0.002***  0.087*  
       
Education group       
Low edu. (N(obs) = 38,142; 
N(individuals) =16,240)  
0.0172* 0.0847*** 0.0994* 0.0124 0.0588* 0.0809 
(0.0102) (0.0304) (0.0563) (0.00986) (0.0305) (0.0564) 
Medium edu. (N(obs) = 61,231; 
N(individuals) =26,264) 
0.0132* 0.0853*** 0.100** 0.0113 0.0666** 0.0781** 
(0.00734) (0.0274) (0.0399) (0.00856) (0.0271) (0.0398) 
High edu. (N(obs) = 35,983; 
N(individuals) =15,134) 
0.00649 0.0526 0.210*** 0.00363 0.0286 0.167** 
(0.00613) (0.0407) (0.0808) (0.00542) (0.0390) (0.0737) 
Chow-test p-value for significant 
differences between education 
groups 
0.033** 0.054* 
       
Household income group       
Low inc. (N(obs) = 60,075; 
N(individuals) =37,988)  
0.00276 0.0600** 0.114*** 0.00156 0.0395 0.105*** 
(0.00196) (0.0245) (0.0406) (0.00207) (0.0241) (0.0406) 
Medium inc. (N(obs) = 58,620; 
N(individuals) =36,851) 
0.0454** 0.0692*** 0.0899** 0.0498** 0.0540** 0.0647 
(0.0210) (0.0246) (0.0445) (0.0230) (0.0247) (0.0440) 
High inc. (N(obs) = 59,757; 
N(individuals) =34,156) 
-0.00659 0.112*** 0.147** -0.0115 0.0888*** 0.109* 
(0.00751) (0.0316) (0.0599) (0.00988) (0.0315) (0.0625) 



































































stay    
Model D 
differences between household 
income groups 
       
European country group       
Central & Eastern Europe 
(N(obs) = 23,542;  
N(individuals) =10,745)  
0.00584 0.0662* 0.137** 0.00468 0.0484 0.124** 
(0.00522) (0.0382) (0.0626) (0.00530) (0.0379) (0.0587) 
Northern Europe             
(N(obs) = 36,132;  
N(individuals) =15,163)  
0.00390 0.0448 0.0752 0.000713 0.0253 0.0890 
(0.00381) (0.0349) (0.0799) (0.00287) (0.0343) (0.0803) 
Southern Europe              
(N(obs) = 37,023;  
N(individuals) =16,301) 
0.0337* 0.103*** 0.0564 0.0374 0.0715** 0.00363 
(0.0185) (0.0333) (0.0534) (0.0231) (0.0329) (0.0541) 
Western Europe               
(N(obs) = 74,252;  
N(individuals) =29,384) 
0.00713* 0.0790*** 0.149*** 0.00664 0.0684*** 0.124*** 
(0.00426) (0.0234) (0.0419) (0.00542) (0.0231) (0.0421) 
Chow-test p-value for significant 
differences between household 
income groups 
0.045** 0.061* 
Standard errors9 in parentheses. *** p<0.01, ** p<0.05, * p<0.1 
Reference categories: No diabetes, other marital status different from married, unemployed or homemaker, no education, 
normal weight, no functional impairment, wave 1, Germany. 
Model A adjusted for the interaction between sociodemographic characteristics at their baseline values (age, gender, 
marital and employment status and education level) and healthy lifestyle factors (having underweight, overweight or 
obesity, and being a current smoker) and time dummies; and having diabetes, as well as time and country dummies. In 
Model B, we also control for non-related diabetes clinical complications, such as chronic lung disease and gastric ulcer. 
Diabetes-related conditions were included in model C (cancer, cardiovascular risk factors (hypertension and cholesterol), 
and cardiovascular diseases (heart problems and stroke). Moreover, in Model D the three categories referring to functional 
impairment (mild, moderate and severe impairment) were added. 
 
                                                          
9 Clustering standard errors implies that we are assuming independence across clusters (which would be survey 
respondents in our case), but correlations within clusters (Heij et al., 2004). Moreover, clustering standard errors 
will lead to larger confidence intervals and, thus, fewer variables being statistically significant in the regression 
models. For example, for one regressor, clustering standard errors will increase the default standard error (that 
is, without clustering) by √1𝜌𝑥𝜌𝜀(𝑁 − 1), where 𝜌𝑥 is the within-cluster (within-individuals) correlation of  














Table 3: Two-part model: results of the effect of diabetes from the random-effects logit model for 











on the age at 





the odds of 
having died    
Model D 
Coefficient 
on the age 
at death    
Model D 
Whole Sample  
(N(obs) = 142,378; 
N(individuals) =69,595)  
 
0.0277*** -0.00506 0.0230*** 0.0297 
(0.00265) (0.0967) (0.00256) (0.0977) 
Gender     
Female (N(obs) = 78,810; 
N(individuals) =38,525)  
0.0189*** 0.0947 0.0164*** 0.119 
(0.00252) (0.133) (0.00254) (0.132) 
Male (N(obs) = 63,658; 
N(individuals) =31,070) 
0.0324*** -0.0774 0.0269*** -0.0297 
(0.00339) (0.133) (0.00337) (0.135) 
Chow-test p-value for significant 
differences between genders 
0.000*** 0.004*** 
     
Age group     
Age 50 - 65 (N(obs) = 83,390; 
N(individuals) =41,964)  
0.0179*** 0.0906 0.0163*** 0.102 
(0.00300) (0.227) (0.00302) (0.227) 
Age 65 - 80 (N(obs) = 71,146; 
N(individuals) =36,038) 
0.0359*** -0.0492 0.0280*** 0.0197 
(0.00436) (0.126) (0.00411) (0.128) 
Age 80+ (N(obs) = 18,672; 
N(individuals) =10,436) 
0.0557*** 0.0684 0.0464*** 0.0965 
(0.0112) (0.146) (0.0111) (0.147) 
Chow-test p-value for significant 
differences between age groups 
0.038** 0.047** 
     
Education group     
Low edu. (N(obs) = 38,142; 
N(individuals) =16,240)  
0.0218*** 0.0795 0.0156*** 0.116 
(0.00446) (0.181) (0.00448) (0.183) 
Medium edu. (N(obs) = 61,231; 
N(individuals) =26,264) 
0.0197*** 0.222 0.0173 0.230 
(0.00324) (0.199) (0.002) (0.203) 
High edu. (N(obs) = 35,983; 
N(individuals) =15,134) 
0.0139*** -0.0238 0.0127*** -0.0141 
(0.0032) (0.193) (0.0027) (0.309) 
Chow-test p-value for significant 
differences between education 
groups 
0.053* 0.061* 
     
Household income group     
Low inc. (N(obs) = 54,178; 
N(individuals) =31,964)  
0.0326*** -0.0347 0.0273*** -0.0210 
(0.00487) (0.123) (0.00478) (0.126) 
Medium inc. (N(obs) = 58,620; 
N(individuals) =36,851) 
0.0372*** 0.195 0.0316*** 0.278* 
(0.00429) (0.145) (0.00412) (0.148) 
High inc. (N(obs) = 59,757; 
N(individuals) =34,156) 
0.0143*** -0.394* 0.0106*** -0.387* 
(0.00331) (0.206) (0.00318) (0.203) 
Chow-test p-value for significant 
differences between household 
income groups 
0.000*** 0.000*** 
     
European country group     























on the age at 





the odds of 
having died    
Model D 
Coefficient 
on the age 
at death    
Model D 
(N(obs) = 23,542;  
N(individuals) =10,745)  
(0.00614) (0.186) (0.00590) (0.197) 
Northern Europe             
(N(obs) = 36,132;  
N(individuals) =15,163)  
0.0289*** 0.0239 0.0234*** 0.0206 
(0.00663) (0.193) (0.00644) (0.191) 
Southern Europe              
(N(obs) = 37,023;  
N(individuals) =16,301) 
0.0448*** -0.115 0.0366*** -0.103 
(0.00637) (0.170) (0.00610) (0.168) 
Western Europe               
(N(obs) = 74,252;  
N(individuals) =29,384) 
0.0187*** 0.146 0.0161*** 0.183 
(0.00379) (0.188) (0.00371) (0.191) 
Chow-test p-value for significant 
differences between household 
income groups 
0.002*** 0.013** 
Standard errors in parentheses9. *** p<0.01, ** p<0.05, * p<0.1 
Reference categories: No diabetes, other marital status different from married, unemployed or 
homemaker, no education, normal weight, no functional impairment, wave 1, Germany. 
Model A adjusted for the interaction between sociodemographic characteristics at their baseline values 
(age, gender, marital and employment status and education level) and healthy lifestyle factors (having 
underweight, overweight or obesity, and being a current smoker) and time dummies; and having diabetes, 
as well as time and country dummies. In Model B, we also control for non-related diabetes clinical 
complications, such as chronic lung disease and gastric ulcer. Diabetes-related conditions were included in 
model C (cancer, cardiovascular risk factors (hypertension and cholesterol), and cardiovascular diseases 
(heart problems and stroke). Moreover, in Model D the three categories referring to functional 
impairment (mild, moderate and severe impairment) were added. 
 
 
Figure 1 Kaplan-Meier survival curves for age at death by diabetes status 
 

















Healthy people refers to the healthy individuals with no diabetes nor any other chronic disease included in the 
analysis (chronic lung disease, gastric ulcer, cancer, high blood pressure, cholesterol, heart problems, stroke, 
mild functional impairment, moderate functional impairment, and severe functional impairment). 
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